Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANTHEON
NCT07257198Phase 3Recruiting
- Sponsor
- Montréal Heart Institute
- Start
- Mar 2026
- Primary completion
- Jan 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in myocardial infarction (MI), sponsored by Montréal Heart Institute. Started Mar 2026; status: recruiting.
02
Drugs
ticagrelor
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT07257198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07257198.